Exact Sciences (EXAS) Tops Q3 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Wall Street ends higher as tech rebounds before Nvidia results
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
Exact Sciences Announces Third Quarter 2022 Results
November 3, 2022 4:05 PM EDTReports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
Third quarter highlights
Total third quarter revenue, excluding COVID-19 testing, increased 20 percent compared to the third quarter of 2021, with Screening revenue of $361 million and Precision Oncology revenue of $151 millionFull-year revenue guidance raised by $33 million and operating expense guidance lowered by $113 million at the midpointsAdjusted EBITDA profitability now expected in the third quarter of 2023, ahead of previous target of 2024MADISON, Wis., Nov. 3, 2022 /PRNewswire/... More
